Washington, D.C.—Congress yesterday failed to pass legislation that would appropriate $100,000 for FDA to perform a Health Hazard Evaluation on cannabidiol (CBD), instead creating a conference report that directs funding for research, policy evaluation, market surveillance, and enforcement discretion related to CBD and hemp. However, a conference report does not...
Washington, D.C.—The Natural Products Association (NPA) submitted comments to the House Energy and Commerce Committee (ECC) regarding Good Manufacturing Practices (GMPs) for cosmetic products, according to a press release. The comments note that in the past, NPA has asked for amendments to the Federal Food, Drug and Cosmetic Act (FDCA)...
Silver Spring, MD—The U.S. Food and Drug Administration (FDA) announced that warning letters were issued to 15 companies for illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The 15 companies that received warning letters (with links to the letters):...
Washington, D.C.—Representative Buddy Carter (R-GA) and other lawmakers asked IRS Commissioner Charles P. Rettig to allow selected categories of nutritional supplements to be considered “medical expenses” under Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs), according to a press release from the Natural Products Association (NPA).
Washington, D.C.—The New Jersey State Senate Health, Human Services, and Senior Citizens Committee today unanimously passed a resolution asking the U.S. Congress to set a safe level for CBD consumption, according to a press release from the Natural Products Association (NPA). President and CEO Daniel Fabricant, Ph.D., testified at the...
Washington, D.C.—The New Jersey Senate has introduced a resolution calling on Congress and the President to “establish a safe daily level of consumption of cannabidiol through legislation,” according to a press release from the Natural Products Association (NPA). New Jersey Senate Resolution No. 163 will be heard in the New...
Washington, D.C—The Natural Products Association (NPA) has been granted observer status by Codex Alimentarius Commission, according to a press release. This recognition means that NPA will have the opportunity to contribute expertise, comments, and recommendations to advance health standards worldwide—including supporting updates to international food and dietary supplement standards to...
Washington, D.C.—President Trump announced his intent to nominate Stephen Hahn, a cancer specialist and hospital administrator, to lead the FDA. According to Politico, this would be Dr. Hahn’s first public service post in 25 years, if the Senate confirms him. Dr. Hahn was chairman of the radiation oncology department at...
Washington, D.C.—A new poll shows that 44% of Americans are less likely to use cannabidiol (CBD) products after learning that the FDA has no standards in place to protect consumers, including 30% who say they would be far less likely to use the products, according to the Natural Products Association...
Washington, D.C.—The U.S. Senate Agriculture Appropriations Committee failed to include legislation passed by the House of Representatives that would appropriate $100,000 for FDA to perform an evaluation and set a safe level of CBD for consumers to use each day, according to a press release from the Natural Products Association...
